Roche Africa

Roche Africa Roche is a global pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people’s lives.

The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. We partner with national, regional and local stakeholders to identify underlying access issues, then work with local partners on solutions that catalyse exponential change. We take a person-centered approach to health, so that the solutions we design together solve the challenges people face at each step of their health journey: from awareness to diagnosis, to treatment and ongoing care. When working with partners for systems-level change across Africa, we know that we can never lose sight of the individual. Together with our partners, we put people at the heart of everything we do, so that we can all support the whole system and care for the whole person.

08/04/2026

What happens when you bring the right voices together?

At 2026 in Nairobi, we convened policymakers, journalists, NGOs and health leaders from across the continent around one shared question: what is the true value of investing in health?

Understanding the societal impact of health doesn’t happen in isolation — it happens through dialogue.

Across conversations, one idea became clear:
Health is not a cost, but a driver of stronger families, more resilient communities and sustainable growth.

This video captures just a glimpse of those exchanges — the discussions, perspectives and connections that help reframe how we think about healthcare.

Because when we connect voices, we unlock new ways to see the value of investing in people.

Many African laboratories already have molecular testing platforms in place.When these systems are integrated across HIV...
27/03/2026

Many African laboratories already have molecular testing platforms in place.

When these systems are integrated across HIV, TB and emerging pathogens, they become more efficient, more sustainable and better prepared for future health threats.

Integrated diagnostics reduce duplication, optimise resources and ensure testing capacity remains active year-round.

Stronger laboratory networks today strengthen pandemic preparedness tomorrow.

Africa has made strong progress against over the past decade. To build on this,on , Roche is launching Integration Ac...
24/03/2026

Africa has made strong progress against over the past decade. To build on this,
on , Roche is launching Integration Accelerated to help maintain and increase that progress in a sustainable way.

By integrating TB and other critical testing onto existing HIV diagnostic infrastructure, countries can expand access, improve efficiency and strengthen health systems without additional investment.

We do not always need new systems. We need to use existing systems better.


reminds us that early detection saves lives.TB spreads through the air. Symptoms can remain mild for months. Delayed t...
24/03/2026

reminds us that early detection saves lives.

TB spreads through the air. Symptoms can remain mild for months. Delayed testing fuels transmission.

Rapid, accurate diagnostics support timely treatment and protect communities.

Ending TB requires sustained investment, integrated systems and coordinated partnership.

The tools exist. The responsibility is shared.

روش تتمنى أن يكون هذا العيد مناسبة للفرح والصحة والعافية لكم ولأحبائكم. في عيد الفطر، نحتفي في روش بقيمة الصحة التي تجمع...
19/03/2026

روش تتمنى أن يكون هذا العيد مناسبة للفرح والصحة والعافية لكم ولأحبائكم. في عيد الفطر، نحتفي في روش بقيمة الصحة التي تجمعنا جميعًا. عيدكم مبارك

Roche vous souhaite un Aid rempli de joie, de santé et de moments précieux avec vos proches.
En ce jour de fête, célébrons ensemble le cadeau de la santé.

, though preventable and curable when diagnosed early, needs more diagnostic investment across African health systems.F...
18/03/2026

, though preventable and curable when diagnosed early, needs more diagnostic investment across African health systems.

Funding constraints continue to limit access to prevention, screening and timely treatment in parts of Africa, but this can change.

Investment in diagnostics delivers measurable returns: earlier treatment, fewer hospitalisations, reduced transmission and stronger economies.

Sustainable domestic financing for integrated testing platforms strengthens everyday healthcare and builds resilience between outbreaks.

is preventable. TB is curable.Still, tuberculosis remains one of the world’s deadliest infectious diseases; and Africa...
16/03/2026

is preventable.
TB is curable.

Still, tuberculosis remains one of the world’s deadliest infectious diseases; and Africa carries a disproportionate share of the burden.

Early diagnosis changes outcomes. When testing is accessible, patients begin treatment sooner, transmission declines and health systems carry less strain.

As we move towards on Tuesday, 24 March, strengthening access to timely diagnostics remains critical across the continent.

Collaborative partnerships are helping strengthen cancer care for women across Africa.Improving access to diagnostics su...
27/02/2026

Collaborative partnerships are helping strengthen cancer care for women across Africa.

Improving access to diagnostics supports earlier detection and better outcomes.

Investing in diagnostics and innovation supports stronger, more resilient healthcare systems across Africa.Diagnostics a...
25/02/2026

Investing in diagnostics and innovation supports stronger, more resilient healthcare systems across Africa.

Diagnostics are foundational to sustainable cancer care.

Addressing cancer in Africa requires collaboration across the healthcare ecosystem.Partnerships help strengthen diagnost...
23/02/2026

Addressing cancer in Africa requires collaboration across the healthcare ecosystem.

Partnerships help strengthen diagnostics, expand access to testing and build more resilient health systems.

Breast cancer in Africa is becoming an economic and societal crisis.More women — including younger women — are being dia...
20/02/2026

Breast cancer in Africa is becoming an economic and societal crisis.

More women — including younger women — are being diagnosed too late.
The impact goes beyond health: it destabilizes families, households, and national development.

The disease already costs African economies an estimated $10.3 billion.

Investing in health is no longer optional. It’s a societal and economic imperative.

So the real question is:
How can investment, technology, and innovation transform breast cancer care?

From digital infrastructure to smarter capital allocation, innovation can remove barriers to care, expand access, and dramatically improve patient outcomes. Technology isn’t just a tool — it’s an enabler and efficiency multiplier.

To explore this further, listen to the latest episode of the Africa Health Ventures podcast, recorded during Africa Tech Festival .

🎧 Featuring Maturin Tchoumi, Thom Renwick, Dr. Kathryn Malherbe, Dr. Carol-Ann Benn, in conversation with Rowena Luk.

🔗 https://rowenaluk.substack.com/p/how-the-fight-against-breast-cancer

Early testing plays a critical role in improving cancer outcomes.When cancer is detected earlier, treatment options expa...
20/02/2026

Early testing plays a critical role in improving cancer outcomes.

When cancer is detected earlier, treatment options expand and survival rates improve, benefiting families and communities alike.

Address

Building E, Hertford Office Park, 90 Bekker Road
Midrand
1686

Website

Alerts

Be the first to know and let us send you an email when Roche Africa posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category